← Leaderboards
Shinghua Ding
University Of Missouri-Columbia
$7,758,256
Attributed
$7,758,256
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,758,256 · 5
By mechanism
R01$7,366,230 · 4
R21$392,026 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoBrainMouse ModelTwo-PhotonCessation Of LifeNeuronsTechnologyImageMolecularElectrophysiology (Science)PlayPathway InteractionsBrain InjuriesInsightSignal TransductionNeuron LossNeurogliaBaseMediatingIschemiaMicroscopyGlutamatesIschemic StrokeAcute
Grant awards (21)
Novel mechanisms of metabolic reprogramming of reactive astrocytes and brain repair after focal cerebral ischemia$622,881
R01 · FY2025 · NS · contact PI
Pathogenesis and motor neuron degeneration of a novel disease associated with a P158A mutation in NAMPT$407,112
R01 · FY2025 · NS · contact PI
Pathogenesis and motor neuron degeneration of a novel disease associated with a P158A mutation in NAMPT$440,488
R01 · FY2024 · NS · contact PI
Pathogenesis and motor neuron degeneration of a novel disease associated with a P158A mutation in NAMPT$479,992
R01 · FY2023 · NS · contact PI
A novel therapeutic approach for Alzheimer Disease (AD)$392,026
R21 · FY2023 · AG · contact PI
Pathogenesis and motor neuron degeneration of a novel disease associated with a P158A mutation in NAMPT$499,222
R01 · FY2022 · NS · contact PI
Reactive astrocytes in neural regeneration and brain recovery after focal ischemic stroke$351,064
R01 · FY2022 · NS · contact PI
Reactive astrocytes in neural regeneration and brain recovery after focal ischemic stroke$351,064
R01 · FY2021 · NS · contact PI
Reactive astrocytes in neural regeneration and brain recovery after focal ischemic stroke$351,064
R01 · FY2020 · NS · contact PI
Reactive astrocytes in neural regeneration and brain recovery after focal ischemic stroke$357,457
R01 · FY2019 · NS · contact PI
THE ROLE AND MECHANISMS OF PBEF IN ACUTE BRAIN INJURY AND LONG-TERM STROKE OUTCOMES AFTER FOCAL ISCHEMIC STROKE$320,467
R01 · FY2019 · NS · contact PI
Reactive astrocytes in neural regeneration and brain recovery after focal ischemic stroke$365,130
R01 · FY2018 · NS · contact PI
THE ROLE AND MECHANISMS OF PBEF IN ACUTE BRAIN INJURY AND LONG-TERM STROKE OUTCOMES AFTER FOCAL ISCHEMIC STROKE$320,709
R01 · FY2018 · NS · contact PI
THE ROLE AND MECHANISMS OF PBEF IN ACUTE BRAIN INJURY AND LONG-TERM STROKE OUTCOMES AFTER FOCAL ISCHEMIC STROKE$319,539
R01 · FY2017 · NS · contact PI
THE ROLE AND MECHANISMS OF PBEF IN ACUTE BRAIN INJURY AND LONG-TERM STROKE OUTCOMES AFTER FOCAL ISCHEMIC STROKE$317,426
R01 · FY2016 · NS · contact PI
THE ROLE AND MECHANISMS OF PBEF IN ACUTE BRAIN INJURY AND LONG-TERM STROKE OUTCOMES AFTER FOCAL ISCHEMIC STROKE$310,625
R01 · FY2015 · NS · contact PI
The Role of Gliotransmission in Cerebral Ischemia$309,949
R01 · FY2014 · NS · contact PI
The Role of Gliotransmission in Cerebral Ischemia$302,450
R01 · FY2013 · NS · contact PI
The Role of Gliotransmission in Cerebral Ischemia$313,733
R01 · FY2012 · NS · contact PI
The Role of Gliotransmission in Cerebral Ischemia$314,071
R01 · FY2011 · NS · contact PI
The Role of Gliotransmission in Cerebral Ischemia$311,787
R01 · FY2010 · NS · contact PI